ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
EIP Pharma Initiates Neflamapimod Study americanpharmaceuticalreview
July 10, 2019EIP Pharma announced the initiation of a new Phase 2 proof-of-concept study evaluating neflamapimod as a treatment for the cognitive dysfunction associated with Huntington's disease, a rare, genetically inherited disease that causes the nerve cells of ... -
NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical Study
prnasia
July 05, 2019NeuroVive Pharmaceutical AB?(Nasdaq Stockholm: NVP) (OTCQX: NEVPF)?today announced that the company has initiated the second part in its ongoing Phase Ia/b clinical study with KL1333 ...
Pharma Sources Insight January 2025
